Eli Lilly (NY: LLY )

148.10 USD -2.16 (-1.44%)

Official Closing Price Updated: 7:52 PM EDT, Sep 28, 2020 Add to My Watchlist

Price and Volume

Volume	2,427,522
Open	151.00
Bid (Size)	148.15 (1)
Ask (Size)	148.35 (2)
Prev. Close	150.26
Today's Range	147.90 - 151.58
52wk Range	101.36 - 170.75
Shares Outstanding	1,085,430,420
Dividend Yield	1.52%

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Trulicity® (dulaglutide) is now indicated as an adjunct to diet, exercise, and standard of care therapy to reduce the risk of non-fatal stroke in adults with type 2 diabetes mellitus who have multiple

September 22, 2020

New indication reflects distinct patient population in the REWIND study – people with type 2 diabetes with multiple cardiovascular risks or established cardiovascular disease

Verzenio® Significantly Reduced the Risk of Cancer Recurrence by 25% for People with HR+, HER2- High Risk Early Breast Cancer

September 20, 2020

Verzenio in combination with endocrine therapy is the only CDK4 & 6 inhibitor to demonstrate a statistically significant improvement in invasive disease-free survival (IDFS) in early breast cancer

Performance

YTD	+12.02%	+12.02%
1 Month	+0.52%	+0.52%
3 Month	-8.98%	-8.98%
6 Month	+6.98%	+6.98%
1 Year	+32.43%	+32.43%

More News

Innovent and Lilly Release Biomarker Results of TYVYT® (Sintilimab Injection) in Combination with ALIMTA® (Pemetrexed) and Platinum Chemotherapy as First-Line Treatment for Nonsquamous Non-Small Cell

September 20, 2020

CHMP Recommends Approval of Lilly's Baricitinib for the Treatment of Adults with Moderate to Severe Atopic Dermatitis

September 18, 2020

Innovent and Lilly Jointly Release Phase 3 Results of TYVYT® (Sintilimab Injection) in Combination with GEMZAR® (Gemcitabine) and Platinum Chemotherapy as First-Line Treatment for Squamous Non-Small C

September 20, 2020

Baricitinib in Combination with Remdesivir Reduces Time to Recovery in Hospitalized Patients with COVID-19 in NIAID-Sponsored ACTT-2 Trial

September 17, 2020

Playboy Reportedly In Talks For SPAC Merger Targeting Erectile Dysfunction Market

September 23, 2020

P/E Ratio Overview: Eli Lilly

September 22, 2020

3 Stocks to Buy Ahead of the Next Market Crash

September 24, 2020

Stocks With Rising Relative Strength: Eli Lilly

September 24, 2020

Danaher Now #40 Largest Company, Surpassing Eli Lilly

September 21, 2020

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search form

The Punxsutawney Spirit

Eli Lilly (NY: LLY )

Price and Volume

Top News

Performance

More News